Viral infection in renal transplant recipients

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Cukuranovic, Jovana ^a   Ugrenovic, Sladjana ^a   Jovanovic, Ivan ^a   Visnjic, Milan ^a   Stefanovic, Vladisav ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADEFOVIR; CIDOFOVIR; ENTECAVIR; FOSCARNET; GANCICLOVIR; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; LAMIVUDINE; LEFLUNOMIDE; OSELTAMIVIR; QUINOLONE DERIVATIVE; RIBAVIRIN; VALACICLOVIR; VALGANCICLOVIR; VARICELLA ZOSTER VACCINE; ZANAMIVIR;

ADENOVIRUS; ADENOVIRUS INFECTION; BK VIRUS; CORONAVIRUS; CORONAVIRUS INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GRAFT INFECTION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN METAPNEUMOVIRUS INFECTION; INFLUENZA; JC VIRUS; KIDNEY GRAFT; METAPNEUMOVIRUS; METAPNEUMOVIRUS INFECTION; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS INFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RHINOVIRUS; RHINOVIRUS INFECTION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; WEST NILE FLAVIVIRUS; KIDNEY; KIDNEY TRANSPLANTATION; OPPORTUNISTIC INFECTION; VIROLOGY;

HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; VIRUS DISEASES;

EID: 84862311274     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/820621     Document Type: Review

References (151)

1. Patel R., Paya C. V., Infections in solid-organ transplant recipients Clinical Microbiology Reviews 1997 10 1 86 124 (Pubitemid 27042833)
2. Kotton C. N., Fishman J. A., Viral infection in the renal transplant recipient Journal of the American Society of Nephrology 2005 16 6 1758 1774 (Pubitemid 41716482)
3. Tong C. Y. W., Bakran A., Williams H., Cheung C. Y., Peiris J. S. M., Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients Transplantation 2000 70 1 213 216 (Pubitemid 30490783)
4. Kidd I. M., Clark D. A., Sabin C. A., Andrew D., Hassan-Walker A. F., Sweny P., Griffiths P. D., Emery V. C., Prospective study of human betaherpesviruses after renal transplantation. Association of human herpesvirus 7 and cytomegalovirus co- infection with cytomegalovirus disease and increased rejection Transplantation 2000 69 11 2400 2404 (Pubitemid 30409011)
5. Chapenko S., Folkmane I., Tomsone V., Amerika D., Rozentals R., Murovska M., Co-infection of two -herpesviruses (CMV and HHV-7) as an increased risk factor for CMV disease in patients undergoing renal transplantation Clinical Transplantation 2000 14 5 486 492
6. Razonable R. R., Rivero A., Brown R. A., Hart G. D., Espy M. J., van Cruijsen H., Wilson J., Groettum C., Kremers W., Smith T. F., Paya C. V., Detection of simultaneous -herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection Clinical Transplantation 2003 17 2 114 120 (Pubitemid 36833781)
7. Sagedal S., Nordal K. P., Hartmann A., Sund S., Scott H., Degré M., Foss A., Leivestad T., Osnes K., Fauchald P., Rollag H., The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients American Journal of Transplantation 2002 2 9 850 856 (Pubitemid 36306840)
8. Ljungman P., -herpesvirus challenges in the transplant recipient Journal of Infectious Diseases 2002 186 supplement 1 S99 S109
9. Hartmann A., Sagedal S., Hjelmesth J., The natural course of cytomegalovirus infection and disease in renal transplant recipients Transplantation 2006 82 2 S15 S17
10. Rubin R. H., Transplant infectious disease: a work in progress Transplant Infectious Disease 2005 7 2 49 50 (Pubitemid 41337790)
11. Dockell D. H., Paya C. V., Human herpesvirus-6 and-7 in transplantation Reviews in Medical Virology 2001 11 23 36 (Pubitemid 32126887)
12. DesJardin J. A., Cho E., Supran S., Gibbons L., Werner B. G., Snydman D. R., Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients Clinical Infectious Diseases 2001 33 8 1358 1362 (Pubitemid 32955187)
13. Toyoda M., Puliyanda D. P., Amet N., Baden L., Cam V., Radha R., Pao A., Vo A., Bunnapradist S., Moudgil A., Jordan S. C., Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients Transplantation 2005 80 2 198 205 (Pubitemid 41061676)
14. Park S. B., Kwak J. H., Lee K. T., Hwang E. A., Han S. Y., Kim H. T., Cho W. H., Choi M. S., Kim H. C., Polyoma virus-associated nephropathy and concurrent cytomegalovirus infection in the kidney transplant recipients Transplantation Proceedings 2006 38 7 2059 2061 (Pubitemid 46068520)
15. Agrawal V., Gupta R. K., Jain M., Prasad N., Sharma R., Polyomavirus nephropathy and Cytomegalovirus nephritis in renal allograft recipients Indian Journal of Pathology and Microbiology 2010 53 4 672 675
16. Welsh R. M., Selin L. K., No one is naive: the significance of heterologous T-cell immunity Nature Reviews Immunology 2002 2 6 417 426 (Pubitemid 37328749)
17. Selin L. K., Cornberg M., Brehm M. A., Kim S. K., Calcagno C., Ghersi D., Puzone R., Celada F., Welsh R. M., CD8 memory T cells: cross-reactivity and heterologous immunity Seminars in Immunology 2004 16 5 335 347 (Pubitemid 39446560)
18. Selin L. K., Brehm M. A., Naumov Y. N., Cornberg M., Kim S. K., Clute S. C., Welsh R. M., Memory of mice and men: CD8 + T-cell cross-reactivity and heterologous immunity Immunological Reviews 2006 211 164 181 (Pubitemid 43882970)
19. Selin L. K., Brehm M. A., Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity Journal of the American Society of Nephrology 2007 18 8 2268 2277 (Pubitemid 47203841)
20. Weikert B. C., Blumberg E. A., Viral infection after renal transplantation: surveillance and management Clinical Journal of the American Society of Nephrology 2008 3 2 S76 S86
21. Avery R. K., Prophylactic strategies before solid-organ transplantation Current Opinion in Infectious Diseases 2004 17 4 353 356 (Pubitemid 39037530)
22. Halpern S. D., Shaked A., Hasz R. D., Caplan A. L., Informing candidates for solid-organ transplantation about donor risk factors New England Journal of Medicine 2008 358 26 2764 2837
23. Fischer S. A., Avery R. K., Screening of donor and recipient prior to solid organ transplantation American Journal of Transplantation 2009 9 supplement 4 S7 S18
24. Wishart D. S., Metabolomics: the principles and potential applications to transplantation American Journal of Transplantation 2005 5 12 2814 2820 (Pubitemid 43923941)
25. Wishart D., Metabolomics: a complementary tool in renal transplantation Contributions to Nephrology 2008 160 76 87
26. Fiorinia R. N., Nicoud I. B., Fiorini J. H., The use of genomics and proteomics for the recognition of transplantation rejection of solid organs Recent Patents on DNA and Gene Sequences 2009 3 1 1 6
27. Naraqi S., Belshe R. B., Cytomegaloviruses Textbook of Human Virology 1991 2nd St. Louis, Mo, USA Mosby 889 924
28. Brennan D. C., Cytomegalovirus in renal transplantation Journal of the American Society of Nephrology 2001 12 4 848 855 (Pubitemid 32246715)
29. Mwintshi K., Brennan D. C., Prevention and management of cytomegalovirus infection in solid-organ transplantation Expert Review of Anti-Infective Therapy 2007 5 2 295 304 (Pubitemid 46681747)
30. Green M., Avery R., Preiksaitis J., Guidelines for the prevention and management of infectious complications of solid organ transplantation American Journal of Transplantation 2004 4 supplement 10 160 163
31. Humar A., Gillingham K. J., Payne W. D., Dunn D. L., Sutherland D. E. R., Matas A. J., Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients Transplantation 1999 68 12 1879 1883 (Pubitemid 30027341)
32. Toupance O., Bouedjoro-Camus M. C., Carquin J., Novella J. L., Lavaud S., Wynckel A., Jolly D., Chanard J., Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses Transplant International 2000 13 6 413 419
33. Dickenmann M. J., Cathomas G., Steiger J., Mihatsch M. J., Thiel G., Tamm M., Cytomegalovirus infection and graft rejection in renal transplantation Transplantation 2001 71 6 764 767 (Pubitemid 32373691)
34. Helanter I., Koskinen P., Trnroth T., Loginov R., Grnhagen-Riska C., Lautenschlager I., The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients Transplantation 2003 75 11 1858 1864 (Pubitemid 36734643)
35. Sagedal S., Hartmann A., Nordal K. P., Osnes K., Leivestad T., Foss A., Degré M., Fauchald P., Rollag H., Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival Kidney International 2004 66 1 329 337 (Pubitemid 38870110)
36. Shaver M. J., Bonsib S. M., Abul-Ezz S., Barri Y. M., Renal allograft dysfunction associated with cytomegalovirus infection American Journal of Kidney Diseases 1999 34 5 942 946 (Pubitemid 29521714)
37. McLaughlin K., Wu C., Fick G., Muirhead N., Hollomby D., Jevnikar A., Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection Transplantation 2002 74 6 813 816
38. Tong C. Y. W., Bakran A., Peiris J. S. M., Muir P., Simon Herrington C., The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation Transplantation 2002 74 4 576 578 (Pubitemid 34977693)
39. Helanter I., Loginov R., Koskinen P., Trnroth T., Grnhagen-Riska C., Lautenschlager I., Persistent cytomegalovirus infection is associated with increased expression of TGF- 1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts Nephrology Dialysis Transplantation 2005 20 4 790 796 (Pubitemid 40520658)
40. Walker J. K., Scholz L. M., Scheetz M. H., Gallon L. G., Kaufman D. B., Rachwalski E. J., Abecassis M. M., Leventhal J. R., Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction Transplantation 2007 83 7 874 882 (Pubitemid 46682727)
41. Brum S., Nolasco F., Sousa J., Ferreira A., Possante M., Pinto J. R., Barroso E., Santos J. R., Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil Transplantation Proceedings 2008 40 3 752 754 (Pubitemid 351608651)
42. Cytomegalovirus American Journal of Transplantation 2004 4 supplement 10 51 58
43. Paya C. V., Prevention of cytomegalovirus disease in recipients of solid-organ transplants Clinical Infectious Diseases 2001 32 4 596 603 (Pubitemid 32565001)
44. Hodson E. M., Craig J. C., Strippoli G. F. M., Webster A. C., Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients Cochrane Database of Systematic Reviews 2008 16 2
45. BenMarzouk-Hidalgo O. J., Cordero E., Martin-Pea A., Garcia-Prado E., Gentil M. A., Gomez-Bravo M. A., Brrera-Pulido L., Cisneros J. M., Perez-Romero P., Prevention and cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection Antiviral Therapy 2009 14 5 641 647
46. Khoury J. A., Storch G. A., Bohl D. L., Schuessler R. M., Torrence S. M., Lockwood M., Gaudreault-Keener M., Koch M. J., Miller B. W., Hardinger K. L., Schnitzler M. A., Brennan D. C., Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients American Journal of Transplantation 2006 6 9 2134 2143 (Pubitemid 44199547)
47. Reischig T., Jindra P., Hes O., vecov M., Klaboch J., Teka V., Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation American Journal of Transplantation 2008 8 1 69 77
48. Small L. N., Lau J., Snydman D. R., Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies Clinical Infectious Diseases 2006 43 7 869 880 (Pubitemid 44435514)
49. Hodson E. M., Jones C. A., Webster A. C., Strippoli G. F. M., Barclay P. G., Kable K., Vimalachandra D., Craig J. C., Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials The Lancet 2005 365 9477 2105 2115 (Pubitemid 40826968)
50. Paya C., Humar A., Dominguez E., Washburn K., Blumberg E., Alexander B., Freeman R., Heaton N., Pescovitz M. D., Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients American Journal of Transplantation 2004 4 4 611 620 (Pubitemid 38523584)
51. Boivin G., Goyette N., Gilbert C., Roberts N., Macey K., Paya C., Pescovitz M. D., Humar A., Dominguez E., Washburn K., Blumberg E., Alexander B., Freeman R., Heaton N., Covington E., Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients Journal of Infectious Diseases 2004 189 9 1615 1618 (Pubitemid 38648289)
52. Khoury J. A., Brennan D. C., Infection complications in kindney transplant recipients: review of the literature Saudi Journal of Kidney Diseases and Transplantation 2005 16 453 497 (Pubitemid 43123424)
53. Pang X. L., Fox J. D., Fenton J. M., Miller G. G., Caliendo A. M., Preiksaitis J. K., Interlaboratory comparison of cytomegalovirus viral load assays American Journal of Transplantation 2009 9 2 258 268
54. Wolff D. J., Heaney D. L., Neuwald P. D., Stellrecht K. A., Press R. D., Multi-site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology Journal of Molecular Diagnostics 2009 11 2 87 92
55. Babel N., Gabdrakhmanova L., Juergensen J. S., Eibl N., Hoerstrup J., Hammer M., Rosenberger C., Hoeflich C., Frei U., Rohde F., Volk H. D., Reinke P., Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: a single center experience Transplantation 2004 78 2 283 285
56. sberg A., Humar A., Rollag H., Jardine A. G., Mouas H., Pescovitz M. D., Sgarabotto D., Tuncer M., Noronha I. L., Hartmann A., Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients American Journal of Transplantation 2007 7 9 2106 2113 (Pubitemid 47247057)
57. Eid A. J., Razonable R. R., New developments in the management of cytomegalovirus infection after solid organ transplantation Drugs 2010 70 8 965 981
58. John G. T., Manivannan J., Chandy S., Peter S., Fleming D. H., Chandy S. J., Balakrishnan N., Krishnamurthy K., Kirubakaran M. G., Jacob C. K., A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients Transplantation Proceedings 2005 37 10 4303 4305 (Pubitemid 43016014)
59. Battiwalla M., Paplham P., Almyroudis N. G., McCarthy A., Abdelhalim A., Elefante A., Smith P., Becker J., McCarthy P. L., Segal B. H., Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation Transplant Infectious Disease 2007 9 1 28 32
60. Efferth T., Romero M. R., Wolf D. G., Stamminger T., Marin J. J. G., Marschall M., The antiviral activities of artemisinin and artesunate Clinical Infectious Diseases 2008 47 6 804 811
61. Shapira M. Y., Resnick I. B., Chou S., Neumann A. U., Lurain N. S., Stamminger T., Caplan O., Saleh N., Efferth T., Marschall M., Wolf D. G., Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation Clinical Infectious Diseases 2008 46 9 1455 1457 (Pubitemid 351589951)
62. Gmez E., Meln S., De Oa M., Alvarez R., Laures A., Alvarez-Grande J., Disseminated herpes simplex virus infection in a renal transplant patient as possible cause of repeated urinary extravasations Nephron 1999 82 1 59 64 (Pubitemid 29206210)
63. Kang Y. N., Oh H. K., Chang Y. C., Kim H. C., Lee S. L., Hwang M., Park K. K., Systemic herpes simplex virus infection following cadaveric renal transplantation: a case report Transplantation Proceedings 2006 38 5 1346 1347
64. Al Midani A., Pinney J., Field N., Atkinson C., Haque T., Harber M., Fulminant hepatitis following primary herpes simplex virus infection Saudi Journal of Kidney Diseases and Transplantation 2011 22 1 107 111
65. Danve-Szatanek C., Aymard M., Thouvenot D., Morfin F., Agius G., Bertin I., Billaudel S., Chanzy B., Coste-Burel M., Finkielsztejn L., Fleury H., Hadou T., Henquell C., Lafeuille H., Lafon M. E., Le Faou A., Legrand M. C., Maille L., Mengelle C., Morand P., Morinet F., Nicand E., Omar S., Picard B., Pozzetto B., Puel J., Raoult D., Scieux C., Segondy M., Seigneurin J. M., Teyssou R., Zandotti C., Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up Journal of Clinical Microbiology 2004 42 1 242 249 (Pubitemid 38082727)
66. Gourishankar S., McDermid J. C., Jhangri G. S., Preiksaitis J. K., Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era American Journal of Transplantation 2004 4 1 108 115 (Pubitemid 38155496)
67. Fehr T., Bossart W., Wahl C., Binswanger U., Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature Transplantation 2002 73 4 608 611 (Pubitemid 34193625)
68. Duchini A., Goss J. A., Karpen S., Pockros P. J., Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols Clinical Microbiology Reviews 2003 16 3 357 364 (Pubitemid 36871311)
69. Slifkin M., Doron S., Snydman D. R., Viral prophylaxis in organ transplant patients Drugs 2004 64 24 2763 2792 (Pubitemid 40007484)
70. Gulley M. L., Tang W., Using epstein-barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder Clinical Microbiology Reviews 2010 23 2 350 366
71. Styczynski J., Reusser P., Einsele H., de la Camara R., Cordonnier C., Ward K. N., Ljungman P., Engelhard D., Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia Bone Marrow Transplantation 2009 43 10 757 770
72. Taylor A. L., Marcus R., Bradley J. A., Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation Critical Reviews in Oncology/Hematology 2005 56 1 155 167 (Pubitemid 41278654)
73. European best practice guidelines for renal transplantation. Section IV. Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment Nephrology Dialysis Transplantation 2002 17 supplement 4 31 36
74. Opelz G., Naujokat C., Daniel V., Terness P., Dhler B., Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients Transplantation 2006 81 9 1227 1233 (Pubitemid 43804539)
75. Kinch A., berg G., Arvidson J., Falk K., Linde A., Pauksens K., Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction Scandinavian Journal of Infectious Diseases 2007 39 3 235 244 (Pubitemid 46322808)
76. Martinez O. M., De Gruijl F. R., Molecular and immunologic mechanisms of cancer pathogenesis in solid organ transplant recipients American Journal of Transplantation 2008 8 11 2205 2211
77. Swerdlow S. H., Campo E., Jaffe E. S., Pileri S. A., Stein H., Thiele J., Vardiman J., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 4th Lyon, France International Agency for Research on Cancer
78. Shaknovich R., Basso K., Bhagat G., Mansukhani M., Hatzivassiliou G., Murty V. V., Buettner M., Niedobitek G., Alobeid B., Cattoretti G., Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling Haematologica 2006 91 10 1313 1320 (Pubitemid 44569803)
79. Hourigan M. J., Doecke J., Mollee P. N., Gill D. S., Norris D., Johnson D. W., Gandhi M. K., A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation British Journal of Haematology 2008 141 6 904 907 (Pubitemid 351724876)
80. Wagner H. J., Cheng Y. C., Huls M. H., Gee A. P., Kuehnle I., Krance R. A., Brenner M. K., Rooney C. M., Heslop H. E., Prompt versus preemptive intervention for EBV lymphoproliferative disease Blood 2004 103 10 3979 3981 (Pubitemid 38596322)
81. Omar H., Hgglund H., Gustafsson-Jernberg., Leblanc K., Mattsson J., Remberger M., Ringdén O., Sparrelid E., Sundin M., Winiarski J., Yun Z., Ljungman P., Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction Transplant Infectious Disease 2009 11 5 393 399
82. Transplant Work Group KDIGO, KDIGO clinical practice guideline for the care of kidney transplant recipients American Journal of Transplantation 2009 9 supplement 3 S1 S155
83. De Angelis B., Dotti G., Quintarelli C., Huye L. E., Zhang L., Zhang M., Pane F., Heslop H. E., Brenner M. K., Rooney C. M., Savoldo B., Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506) Blood 2009 114 23 4784 4791
84. Heslop H. E., Slobod K. S., Pule M. A., Hale G. A., Rousseau A., Smith C. A., Bollard C. M., Liu H., Wu M. F., Rochester R. J., Amrolia P. J., Hurwitz J. L., Brenner M. K., Rooney C. M., Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Blood 2010 115 5 925 935
85. Savoldo B., Goss J. A., Hammer M. M., Zhang L., Lopez T., Gee A. P., Lin Y. F., Quiros-Tejeira R. E., Reinke P., Schubert S., Gottschalk S., Finegold M. J., Brenner M. K., Rooney C. M., Heslop H. E., Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs) Blood 2006 108 9 2942 2949
86. Frey N. V., Tsai D. E., The management of posttransplant lymphoproliferative disorder Medical Oncology 2007 24 2 125 136 (Pubitemid 350135963)
87. Gross T. G., Treatment for Epstein-Barr virus-associated post-transplant lymphoproliferative disease Herpes 2009 15 3 64 67
88. Pescovitz M. D., Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action American Journal of Transplantation 2006 6 5 I 859 866 (Pubitemid 44356635)
89. Trofe J., Buell J. F., Beebe T. M., Hanaway M. J., First M. R., Alloway R. R., Gross T. G., Succop P., Woodle E. S., Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience American Journal of Transplantation 2005 5 4 I 775 780 (Pubitemid 40461287)
90. Chapenko S., Folkmane I., Ziedina I., Chistyakovs M., Rozentals R., Krumina A., Murovska M., Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy Journal of Clinical Virology 2009 46 1 29 32
91. Boutolleau D., Duros C., Bonnafous P., Caola D., Karras A., Castro N. D., Ouachée M., Narcy P., Gueudin M., Agut H., Gautheret-Dejean A., Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology Journal of Clinical Virology 2006 35 3 257 263 (Pubitemid 43188970)
92. Lusso P., HHV-6 and the immune system: mechanisms of immunomodulation and viral escape Journal of Clinical Virology 2006 37 1 S4 S10
93. Benito N., Ricart M. J., Pumarola T., Marcos M. A., Oppenheimer F., Moreno Camacho A., Infection with human herpesvirus 6 after kidney-pancreas transplant American Journal of Transplantation 2004 4 7 1197 1199 (Pubitemid 38868615)
94. Diociaiuti A., Nanni G., Cattani P., Lesnoni La Parola I., Masini C., Capuano M., Pozzetto U., Fadda G., Castagneto M., Cerimele D., HHV8 in renal transplant recipients Transplant International 2000 13 1 S410 S412
95. Ponticelli C., Herpes viruses and tumours in kidney transplant recipients. the role of immunosuppression Nephrology Dialysis Transplantation 2011 26 6 1769 1775
96. Jalilvand S., Shoja Z., Mokhtari-Azad T., Nategh R., Gharehbaghian A., Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran Infectious Agents and Cancer 2011 6 1, article 5
97. Akbarzadehpasha A., Oliaei F., Asrari M. R., Alizadeh-Navaei R., Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation Saudi Journal of Kidney Diseases and Transplantation 2010 21 6 1044 1047
98. Stallone G., Schena A., Infante B., Di Paolo S., Loverre A., Maggio G., Ranieri E., Gesualdo L., Schena F. P., Grandaliano G., Sirolimus for Kaposi's sarcoma in renal-transplant recipients New England Journal of Medicine 2005 352 13 1317 1323 (Pubitemid 40411498)
99. Friedersdorff F., Giessing M., Roller C., Baumunk D., Deger S., Budde K., Liefeldt L., Hartmann V., Fuller T. F., De novo renal transplantation after Kaposi sarcoma: favorable outcome in a patient receiving sirolimus and mycophenolate-based immunosuppression Case Reports in Dermatology 2010 2 1 32 35
100. Manuelli M., De Luca L., Iaria G., Tatangelo P., Sforza D., Perrone L., Bellini M. I., Angelico R., Anselmo A., Tisone G., Conversion to rapamycin immunosuppression for malignancy after kidney transplantation Transplantation Proceedings 2010 42 4 1314 1316
101. Boratyska M., Watorek E., Smolska D., Patrzaek D., Klinger M., Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies Transplantation Proceedings 2007 39 9 2736 2739 (Pubitemid 350088107)
102. Ramos E., Drachenberg C. B., Wali R., Hirsch H. H., The decade of polyomavirus BK-associated nephropathy: state of affairs Transplantation 2009 87 5 621 630
103. Randhawa P., Ramos E., BK viral nephropathy: an overview Transplantation Reviews 2007 21 2 77 85 (Pubitemid 46825407)
104. Hirsch H. H., Knowles W., Dickenmann M., Passweg J., Klimkait T., Mihatsch M. J., Steiger J., Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients New England Journal of Medicine 2002 347 7 488 496 (Pubitemid 34879336)
105. Hirsch H. H., Brennan D. C., Drachenberg C. B., Ginevri F., Gordon J., Limaye A. P., Mihatsch M. J., Nickeleit V., Ramos E., Randhawa P., Shapiro R., Steiger J., Suthanthiran M., Trofe J., Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations Transplantation 2005 79 10 1277 1286 (Pubitemid 40734783)
106. Jiang M., Abend J. R., Johnson S. F., Imperiale M. J., The role of polyomaviruses in human disease Virology 2009 384 2 266 273
107. Randhawa P., Brennan D. C., BK virus infection in transplant recipients: an overview and update American Journal of Transplantation 2006 6 9 2000 2005 (Pubitemid 44199534)
108. Phillips T., Jacobs R., Ellis E. N., Polyoma nephropathy and progressive multifocal leukoencephalopathy in a renal transplant recipient Journal of Child Neurology 2004 19 4 301 304 (Pubitemid 38660215)
109. Drachenberg C. B., Hirsch H. H., Ramos E., Papadimitriou J. C., Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods Human Pathology 2005 36 12 1245 1255 (Pubitemid 41682279)
110. Randhawa P., Vats A., Shapiro R., Monitoring for polyomavirus BK and JC in urine: comparison of quantitative polymerase chain reaction with urine cytology Transplantation 2005 79 8 984 986 (Pubitemid 40586876)
111. Drachenberg C. B., Hirsch H. H., Papadimitriou J. C., Gosert R., Wali R. K., Munivenkatappa R., Nogueira J., Cangro C. B., Haririan A., Mendley S., Ramos E., Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation Transplantation 2007 84 3 323 330 (Pubitemid 47258319)
112. Funk G. A., Steiger J., Hirsch H. H., Rapid dynamics of polyomavirus type BK in renal transplant recipients Journal of Infectious Diseases 2006 193 1 80 87 (Pubitemid 43032502)
113. Wali R. K., Drachenberg C., Hirsch H., Joshi A., Munivenkatappa R., Portocarrerro M., Weir M., Cooper M., Bartlett S., Ramos E., Intensive versus routine care screening for polyoma viral replication (cluster randomization) and a road map for stepwise modification of immunosuppression therapy American Journal of Transplantation 2008 8 supplement 2 283
114. Hilton R., Tong C. Y. W., Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation Journal of Antimicrobial Chemotherapy 2008 62 5 855 859
115. Fabrizi F., Martin P., Management of hepatitis B and C virus infection before and after renal transplantation Current Opinion in Organ Transplantation 2006 11 6 583 588 (Pubitemid 44786450)
116. Kalia H., Fabrizi F., Martin P., Hepatitis B virus and renal transplantation Transplantation Reviews 2011 25 3 102 109
117. Fabrizi F., Bunnapradist S., Martin P., HBV infection in patients with end-stage renal disease Seminars in Liver Disease 2004 24 1 63 70 (Pubitemid 38738360)
118. Mathurin P., Mouquet C., Poynard T., Sylla C., Benalia H., Fretz C., Thibault V., Cadranel J. F., Bernard B., Opolon P., Coriat P., Bitker M. O., Impact of hepatitis B and C virus on kidney transplantation outcome Hepatology 1999 29 1 257 263 (Pubitemid 29024011)
119. Fabrizi F., Martin P., Dixit V., Kanwal F., Dulai G., HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies American Journal of Transplantation 2005 5 12 2913 2921 (Pubitemid 43923952)
120. Matos C. A. L., Perez R. M., Lemos L. B., Medina-Pestana J. O., Lanzoni V. P., Alberto F. L., Moreira E. S., Silva A. E. B., Ferraz M. L. G., Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection European Journal of Gastroenterology and Hepatology 2007 19 8 653 657 (Pubitemid 47067063)
121. Berger A., Preiser W., Kachel H. G., Strmer M., Doerr H. W., HBV reactivation after kidney transplantation Journal of Clinical Virology 2005 32 2 162 165 (Pubitemid 40093968)
122. Savas N., Colak T., Yilmaz U., Emiroglu R., Haberal M., Hepatitis B virus reactivation after renal transplantation: report of two cases Transplant International 2007 20 3 301 304
123. Grotz W., Rasenack J., Benzing T., Berthold H., Peters T., Walter E., Schollmeyer P., Rump L. C., Occurrence and management of hepatitis B virus reactivation following kidney transplantation Clinical Nephrology 1998 49 6 385 388 (Pubitemid 28271471)
124. Wu W., Chen Y., Ruan B., Li L. J., Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B Hepatobiliary and Pancreatic Diseases International 2005 4 4 530 534 (Pubitemid 41723806)
125. Vajdic C. M., McDonald S. P., McCredie M. R. E., Van Leeuwen M. T., Stewart J. H., Law M., Chapman J. R., Webster A. C., Kaldor J. M., Grulich A. E., Cancer incidence before and after kidney transplantation Journal of the American Medical Association 2006 296 23 2823 2831 (Pubitemid 44969182)
126. Rangel M. C., Coronado V. G., Euler G. L., Strikas R. A., Vaccine recommendations for patients on chronic dialysis Seminars in Dialysis 2000 13 2 101 107
127. De Feo T. M., Grossi P., Poli F., Mozzi F., Messa P., Minetti E., Sandrini S., Boschiero L., Rigotti P., Maresca C., Rolla D., Chiaramonte S., Gotti E., Caldara R., Briano G., Scalamogna M., Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study Transplantation 2006 81 1 76 80 (Pubitemid 43122152)
128. Carbone M., Cockwell P., Neuberger J., Hepatitis C and kidney transplantation International Journal of Nephrology 2011 2011 17
129. Abbott K. C., Lentine K. L., Bucci J. R., Agodoa L. Y., Peters T. G., Schnitzler M. A., The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients American Journal of Transplantation 2004 4 12 2032 2037 (Pubitemid 39611631)
130. A. O. Gheith A., Dilemma of HCV infection in renal transplant recipients International Journal of Nephrology 2011 2011 7
131. Fabrizi F., Lunghi G., Dixit V., Martin P., Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients Alimentary Pharmacology and Therapeutics 2006 24 10 1413 1422 (Pubitemid 44657117)
132. Pageaux G. P., Hilleret M. N., Garrigues V., Bismuth M., Audin-Mamlouk H., Zarski J. P., Mourad G., Pegylated interferon- -based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study Transplant International 2009 22 5 562 567
133. Kamar N., Ribes D., Izopet J., Rostaing L., Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant Transplantation 2006 82 7 853 856 (Pubitemid 44564028)
134. Frassetto L. A., Tan-Tam C., Stock P. G., Renal transplantation in patients with HIV Nature Reviews Nephrology 2009 5 10 582 589
135. Shahinian V., Rajaraman S., Borucki M., Grady J., Hollander W. M., Ahuja
136. Stock P. G., Barin B., Murphy B., Hanto D., Diego J. M., Light J., Davis C., Blumberg E., Simon D., Subramanian A., Millis J. M., Lyon G. M., Brayman K., Slakey D., Shapiro R., Melancon J., Jacobson J. M., Stosor V., Olson J. L., Stablein D. M., Roland M. E., Outcomes of kidney transplantation in HIV-infected recipients New England Journal of Medicine 2010 363 21 2004 2014
137. Cofan F., Trullas J.-C., Cervera C., Oppenheimer F., Moreno A., Campistol J.-M., Mir J.-M., Are HIV-infected donors suitable for renal transplantation? Transplantation 2011 91 4 e22 e23
138. Muller E., Kahn D., Mendelson M., Renal transplantation between HIV-positive donors and recipients New England Journal of Medicine 2010 362 24 2336 2337
139. Boyarsky B. J., Hall E. C., Singer A. L., Montgomery R. A., Gebo K. A., Segev D. L., Estimating the potential pool of HIV-infected deceased organ donors in the United States American Journal of Transplantation 2011 11 6 1209 1217
140. Kumar M. S. A., Sierka D. R., Damask A. M., Fyfe B., Mcalack R. F., Heifets M., Moritz M. J., Alvarez D., Kumar A., Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients Kidney International 2005 67 4 1622 1629 (Pubitemid 40463144)
141. Carter J. T., Melcher M. L., Carlson L. L., Roland M. E., Stock P. G., Thymoglobulin-associated Cd4 + T-cell depletion and infection risk in HIV-infected renal transplant recipients American Journal of Transplantation 2006 6 4 753 760 (Pubitemid 43345013)
142. Echavarra M., Adenoviruses in immunocompromised hosts Clinical Microbiology Reviews 2008 21 4 704 715
143. Pham T. T. N., Burchette J. L., Hale L. P., Fatal disseminated adenovirus infections in immunocompromised patients American Journal of Clinical Pathology 2003 120 4 575 583 (Pubitemid 37186052)
144. Alsaad K. O., Tobar A., Belanger E., Ahmad M., Cattran D. C., Herzenberg A. M., Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft Nephrology Dialysis Transplantation 2007 22 4 1257 1260 (Pubitemid 46523450)
145. Morelon E., Noble C. P., Daoud S., Cahen R., Goujon-Henry C., Weber F., Laurent P. E., Kaiserlian D., Nicolas J. F., Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination Vaccine 2010 28 42 6885 6890
146. Ison M. G., Adenovirus infections in transplant recipients Clinical Infectious Diseases 2006 43 3 331 339 (Pubitemid 44078906)
147. Ison M. G., Green M., Adenovirus in solid organ transplant recipients American Journal of Transplantation 2009 9 supplement 4 S161 S165
148. Rossi S. L., Ross T. M., Evans J. D., West nile virus Clinics in Laboratory Medicine 2010 30 1 47 65
149. Iwamoto M., Jernigan D. B., Guasch A., Trepka M. J., Blackmore C. G., Hellinger W. C., Pham S. M., Zaki S., Lanciotti R. S., Lance-Parker S. E., DiazGranados C. A., Winquist A. G., Perlino C. A., Wiersma S., Hillyer K. L., Goodman J. L., Marfin A. A., Chamberland M. E., Petersen L. R., Transmission of West Nile virus from an organ donor to four transplant recipients New England Journal of Medicine 2003 348 22 2196 2203 (Pubitemid 36618130)
150. Cushing M. M., Brat D. J., Mosunjac M. I., Hennigar R. A., Jernigan D. B., Lanciotti R., Petersen L. R., Goldsmith C., Rollin P. E., Shieh W.-J., Guarner J., Zaki S. R., Fatal West Nile virus encephalitis in a renal transplant recipient American Journal of Clinical Pathology 2004 121 1 26 31 (Pubitemid 38090150)
151. Wadei H., Alangaden G. J., Sillix D. H., El-Amm J. M., Gruber S. A., West M. S., Granger D. K., Garnick J., Chandrasekar P., Migdal S. D., Haririan A., West Nile virus encephalitis: an emerging disease in renal transplant recipients Clinical Transplantation 2004 18 6 753 758 (Pubitemid 39496994)